Library Item - Page 587 of 792 Posts on Medivizor
Navigation Menu

Library Item Posts on Medivizor

Exercise, blood sugar, and insulin: is insulin degludec safe for type 1 diabetics?

Exercise, blood sugar, and insulin: is insulin degludec safe for type 1 diabetics?

Posted by on Dec 14, 2015 in Diabetes mellitus | 2 comments

In a nutshell This study examined the risk of low blood glucose in type 1 diabetics treated with insulin degludec. Some background Patients with type 1 diabetes (T1D) must inject rapid-acting insulin and long-acting insulin each day. Long-acting insulin maintains blood glucose levels at a steady level. Insulin glargine (Lantus) is a...

Read More

Erlotinib treatment following lung cancer progression

Erlotinib treatment following lung cancer progression

Posted by on Dec 14, 2015 in Lung cancer | 0 comments

In a nutshell The authors aimed to determine the effect of erlotinib (Tarceva) in delaying treatment change in patients with progressive lung cancers with and without epidermal growth factor receptor (EGFR) mutations (changes to the cell). Some background Erlotinib is a biological therapy (drug used to stimulate or restore the body's...

Read More

Survival and recurrence in scalp melanoma

Posted by on Dec 14, 2015 in Melanoma | 0 comments

In a nutshell The authors analyzed the patterns of survival and recurrence in patients with scalp (the skin covering the head but not the face) melanoma. Some background Head and neck skin melanomas occur in less than 20% of all cases. It is associated with worse outcome than melanoma of other body parts. Scalp melanoma is part of head and neck...

Read More

Age can affect treatment outcome in hypertension

Age can affect treatment outcome in hypertension

Posted by on Dec 13, 2015 in Hypertension | 0 comments

In a nutshell This study examined the effectiveness of olmesartan (Benicar) combined with either a calcium channel blocker (CCB), or a diuretic, on blood pressure variability in elderly and very elderly hypertensive patients. The authors concluded that olmesartan combined with a CCB led to decreased blood pressure variability only in very elderly...

Read More

A new treatment option for progressive hormone receptor-positive breast cancer

A new treatment option for progressive hormone receptor-positive breast cancer

Posted by on Dec 13, 2015 in Breast cancer | 0 comments

In a nutshell This study examined the effectiveness of palbociclib (Ibrance) in the treatment of hormone receptor-positive breast cancer patients. The authors found that palbociclib treatment increased progression free survival. Some background Major treatment options for hormone receptor-positive (HR+, dependent on the hormones estrogen and/or...

Read More

Everything in moderation: alcohol and the risk of stroke

Everything in moderation: alcohol and the risk of stroke

Posted by on Dec 13, 2015 in Stroke | 0 comments

In a nutshell This study examined the long-term association between alcohol consumption and the risk of stroke. The authors concluded that heavy alcohol consumption increases the risk of stroke. Some background Because stroke is a major cause of both disability and mortality, it is important to understand what risk factors are involved. Some risk...

Read More

Relieving BPH symptoms with a WAVE

Relieving BPH symptoms with a WAVE

Posted by on Dec 13, 2015 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study investigated the effects of WAVE (Water Vapor Energy Ablation) – a new procedure to relieve urinary symptoms due to benign prostate hyperplasia (BPH). WAVE was found to be a simple, effective and safe method of treating BPH symptoms.  Some background Benign prostatic hyperplasia may lead to troublesome urinary...

Read More

Can morning blood glucose levels predict low blood glucose at night in diabetics?

Can morning blood glucose levels predict low blood glucose at night in diabetics?

Posted by on Dec 13, 2015 in Diabetes mellitus | 0 comments

In a nutshell This study examined whether glucose levels can predict night-time hypoglycaemia in type 1 diabetics.   Some background Lower blood glucose (sugar) levels in patients with type 1 diabetes can reduce the risk of developing complications. However, patients then have a higher risk of experiencing hypoglycemia (dangerously low...

Read More

Does canagliflozin increase the risk of bone fractures in type 2 diabetics?

Posted by on Dec 13, 2015 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effects of canagliflozin on the risk of bone fractures in type 2 diabetic patients. Some background Patients with type 2 diabetes (T2D) have an increased risk of bone fractures. Many factors are thought to be responsible for the higher risk. It is believed that high blood glucose levels can increase...

Read More